抗脂抗体,风湿免疫炎症和冠状动脉静脉静脉静脉静脉静脉静脉静脉静脉静脉静脉静脉静脉静脉静脉静脉
Wenxing Mao1, Zhiming Wu1, You Wei1
1Department of Cardiology, Nanjing First Hospital, Nanjing Medical University, Nanjing, Jiangsu, China.
Frontiers in cardiovascular medicine
|January 30, 2026
概括
抗脂抗体 (aPL) 和高素-6 (IL-6) 水平与药物排泄支架 (DES) 植入后的内置支架缩 (ISR) 和目标损伤再血管化 (TLR) 有关. 结合这些免疫标志物可以提高心血管事件的风险预测.
科学领域:
- 心血管医学 心血管医学
- 免疫学 免疫学 免疫学
- 干预心脏病学 干预心脏病学
背景情况:
- 药物排泄支架 (DES) 植入后的内置支架缩 (ISR) 是一个重大问题.
- 抗脂抗体 (aPL) 和系统性风湿免疫炎症 (RII) 在ISR发展中的潜在作用需要进一步研究.
研究的目的:
- 为了前性地评估aPL,炎症生物标志物和ISR之间的关联,在一个大规模的中国DES接收者队列中.
- 为了确定是否结合免疫标志物可以改善ISR和目标损伤重血管化 (TLR) 的预测.
主要方法:
- 一项针对2503名接受新一代DES的患者的前性队列研究.
- 评估手术前的aPL和炎症生物标志物,包括IL-6.
- 在12个月后使用冠状动脉血管学或CCTA评估ISR和TLR.
- 用于调整分析的多变量逻辑回归和考克斯模型.
主要成果:
- 任何aPL阳性 (OR 1.92) 和更高的IL-6水平 (OR 1.25每倍) 都与ISR独立相关.
- 添加aPL和IL-6显著改善了ISR风险的歧视和重新分类 (AUC为0.79比0.72).
- aPL阳性 (HR 2.08) 和较高的IL-6水平 (HR 1.29每倍) 与TLR风险增加有关.
结论:
- 基线aPL血清阳性和IL-6升高是DES植入后12个月ISR和TLR的独立预测因素.
- 整合像aPL和IL-6这样的免疫标志物可以比传统的临床因素更好地预测心血管风险.
- 需要进一步的外部验证和干预研究来证实这些发现.
相关概念视频
Inflammation
62.0K
Overview
62.0K
What is the Immune System?
127.8K
Overview
127.8K
Antibody Structure
65.5K
Overview
Antibodies, also known as immunoglobulins (Ig), are essential players of the adaptive immune system. These antigen-binding proteins are produced by B cells and make up 20 percent of the total blood plasma by weight. In mammals, antibodies fall into five different classes, which each elicits a different biological response upon antigen binding.
The Y-Shaped Structure of Antibodies Consists of Four Polypeptide Chains
Antibodies consist of four polypeptide chains: two identical heavy...
Antibodies, also known as immunoglobulins (Ig), are essential players of the adaptive immune system. These antigen-binding proteins are produced by B cells and make up 20 percent of the total blood plasma by weight. In mammals, antibodies fall into five different classes, which each elicits a different biological response upon antigen binding.
The Y-Shaped Structure of Antibodies Consists of Four Polypeptide Chains
Antibodies consist of four polypeptide chains: two identical heavy...
65.5K
Rheumatic Heart Disease I: Introduction
519
Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
519
Humoral Immune Responses
83.9K
Overview
83.9K
Rheumatic Heart Disease IV: Nursing Management
330
AssessmentA comprehensive assessment is essential in managing a patient with rheumatic heart disease (RHD). Begin with obtaining a detailed medical history, including recent streptococcal infections, a history of rheumatic fever, or previously diagnosed rheumatic heart disease. Assess the patient for symptoms such as fever, chest pain, widespread joint pain (arthralgia), tachycardia, pericardial friction rub, muffled heart sounds, heart murmurs, peripheral edema, subcutaneous nodules, and...
330


